カテゴリー： 世界, 医療/バイオ, LP Information

世界の慢性心不全（CHF）用装置市場予測 2023年-2029年

【英語タイトル】Global Chronic Heart Failure (CHF) Devices Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4350）・商品コード：LP23MY4350
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の慢性心不全（CHF）用装置市場」は、過去の販売実績から2022年の世界の慢性心不全（CHF）用装置の総販売量を検討し、2023年から2029年の予測される慢性心不全（CHF）用装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の慢性心不全（CHF）用装置の市場規模を掲載し、XXX百万米ドル規模の世界の慢性心不全（CHF）用装置市場の詳細な分析を提供します。本インサイトレポートは、世界の慢性心不全（CHF）用装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の慢性心不全（CHF）用装置市場における各社の独自のポジションをより深く理解するために、慢性心不全（CHF）用装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の慢性心不全（CHF）用装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。慢性心不全（CHF）用装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。慢性心不全（CHF）用装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。慢性心不全（CHF）用装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

慢性心不全（CHF）用装置の世界主要メーカーとしては、Medtronic、 Abbott、 Johnson & Johnson、 Stanley Pharmaceuticals、 New Haven Pharmaceuticals, Inc.、 Boston Scientific Corporation、 HeartWare、 Biovail Corporation、 Abiomed、 Symplmed Pharmaceuticals、 Berlin Heart GmbH、 ReliantHeart, Inc.、 Cardiokinetix、 Biotronik、 Jarvik Heartなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の慢性心不全（CHF）用装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では慢性心不全（CHF）用装置市場をセグメンテーションし、種類別 (植込み型左心室補助人工心臓（LVAD）、両心室ペースメーカー、植込み型除細動器（ICD）、持続陽圧呼吸装置（CPAP）、二段階気道陽圧装置（BiPAP）、心臓ポンプ)、用途別 (病院、診療所、家庭、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：植込み型左心室補助人工心臓（LVAD）、両心室ペースメーカー、植込み型除細動器（ICD）、持続陽圧呼吸装置（CPAP）、二段階気道陽圧装置（BiPAP）、心臓ポンプ

・用途別区分：病院、診療所、家庭、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の慢性心不全（CHF）用装置市場の10年間の市場状況・展望は？
・世界および地域別に見た慢性心不全（CHF）用装置市場成長の要因は何か？
・慢性心不全（CHF）用装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・慢性心不全（CHF）用装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：慢性心不全（CHF）用装置の年間販売量2018-2029、地域別現状・将来分析
・慢性心不全（CHF）用装置の種類別セグメント：植込み型左心室補助人工心臓（LVAD）、両心室ペースメーカー、植込み型除細動器（ICD）、持続陽圧呼吸装置（CPAP）、二段階気道陽圧装置（BiPAP）、心臓ポンプ
・慢性心不全（CHF）用装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・慢性心不全（CHF）用装置の用途別セグメント：病院、診療所、家庭、その他
・慢性心不全（CHF）用装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の慢性心不全（CHF）用装置市場
・企業別のグローバル慢性心不全（CHF）用装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の慢性心不全（CHF）用装置の年間売上：2018-2023年の売上、市場シェア
・企業別の慢性心不全（CHF）用装置販売価格
・主要企業の慢性心不全（CHF）用装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

慢性心不全（CHF）用装置の地域別レビュー
・地域別の慢性心不全（CHF）用装置市場規模2018-2023：年間販売量、売上
・主要国別の慢性心不全（CHF）用装置市場規模2018-2023：年間販売量、売上
・南北アメリカの慢性心不全（CHF）用装置販売の成長
・アジア太平洋の慢性心不全（CHF）用装置販売の成長
・ヨーロッパの慢性心不全（CHF）用装置販売の成長
・中東・アフリカの慢性心不全（CHF）用装置販売の成長

南北アメリカ市場
・南北アメリカの国別の慢性心不全（CHF）用装置販売量、売上（2018-2023）
・南北アメリカの慢性心不全（CHF）用装置の種類別販売量
・南北アメリカの慢性心不全（CHF）用装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の慢性心不全（CHF）用装置販売量、売上（2018-2023）
・アジア太平洋の慢性心不全（CHF）用装置の種類別販売量
・アジア太平洋の慢性心不全（CHF）用装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の慢性心不全（CHF）用装置販売量、売上（2018-2023）
・ヨーロッパの慢性心不全（CHF）用装置の種類別販売量
・ヨーロッパの慢性心不全（CHF）用装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の慢性心不全（CHF）用装置販売量、売上（2018-2023）
・中東・アフリカの慢性心不全（CHF）用装置の種類別販売量
・中東・アフリカの慢性心不全（CHF）用装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・慢性心不全（CHF）用装置の製造コスト構造分析
・慢性心不全（CHF）用装置の製造プロセス分析
・慢性心不全（CHF）用装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・慢性心不全（CHF）用装置の主要なグローバル販売業者
・慢性心不全（CHF）用装置の主要なグローバル顧客

地域別の慢性心不全（CHF）用装置市場予測レビュー
・地域別の慢性心不全（CHF）用装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・慢性心不全（CHF）用装置の種類別市場規模予測
・慢性心不全（CHF）用装置の用途別市場規模予測

主要企業分析
Medtronic、 Abbott、 Johnson & Johnson、 Stanley Pharmaceuticals、 New Haven Pharmaceuticals, Inc.、 Boston Scientific Corporation、 HeartWare、 Biovail Corporation、 Abiomed、 Symplmed Pharmaceuticals、 Berlin Heart GmbH、 ReliantHeart, Inc.、 Cardiokinetix、 Biotronik、 Jarvik Heart
・企業情報
・慢性心不全（CHF）用装置製品
・慢性心不全（CHF）用装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Chronic Heart Failure (CHF) Devices Industry Forecast” looks at past sales and reviews total world Chronic Heart Failure (CHF) Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Chronic Heart Failure (CHF) Devices sales for 2023 through 2029. With Chronic Heart Failure (CHF) Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Heart Failure (CHF) Devices industry.
This Insight Report provides a comprehensive analysis of the global Chronic Heart Failure (CHF) Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Heart Failure (CHF) Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chronic Heart Failure (CHF) Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Heart Failure (CHF) Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Heart Failure (CHF) Devices.
The global Chronic Heart Failure (CHF) Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chronic Heart Failure (CHF) Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chronic Heart Failure (CHF) Devices players cover Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Biovail Corporation and Abiomed, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Heart Failure (CHF) Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Implantable Left Ventricular Assist Device (LVAD)
Biventricular Pacemaker
Implantable Cardioverter-defibrillators (ICDs)
Continuous Positive Air Pressure Device (CPAP)
Bi-level Positive Air Pressure Device (BiPAP)
Heart Pumps
Segmentation by application
Hospital
Clinic
Household
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Medtronic
Abbott
Johnson & Johnson
Stanley Pharmaceuticals
New Haven Pharmaceuticals, Inc.
Boston Scientific Corporation
HeartWare
Biovail Corporation
Abiomed
Symplmed Pharmaceuticals
Berlin Heart GmbH
ReliantHeart, Inc.
Cardiokinetix
Biotronik
Jarvik Heart
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chronic Heart Failure (CHF) Devices market?
What factors are driving Chronic Heart Failure (CHF) Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Heart Failure (CHF) Devices market opportunities vary by end market size?
How does Chronic Heart Failure (CHF) Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Chronic Heart Failure (CHF) Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Chronic Heart Failure (CHF) Devices by Country/Region, 2018, 2022 & 2029
2.2 Chronic Heart Failure (CHF) Devices Segment by Type
2.2.1 Implantable Left Ventricular Assist Device (LVAD)
2.2.2 Biventricular Pacemaker
2.2.3 Implantable Cardioverter-defibrillators (ICDs)
2.2.4 Continuous Positive Air Pressure Device (CPAP)
2.2.5 Bi-level Positive Air Pressure Device (BiPAP)
2.2.6 Heart Pumps
2.3 Chronic Heart Failure (CHF) Devices Sales by Type
2.3.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Chronic Heart Failure (CHF) Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2018-2023)
2.4 Chronic Heart Failure (CHF) Devices Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.4.4 Others
2.5 Chronic Heart Failure (CHF) Devices Sales by Application
2.5.1 Global Chronic Heart Failure (CHF) Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Chronic Heart Failure (CHF) Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Application (2018-2023)
3 Global Chronic Heart Failure (CHF) Devices by Company
3.1 Global Chronic Heart Failure (CHF) Devices Breakdown Data by Company
3.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Company (2018-2023)
3.1.2 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company (2018-2023)
3.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Chronic Heart Failure (CHF) Devices Revenue by Company (2018-2023)
3.2.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2018-2023)
3.3 Global Chronic Heart Failure (CHF) Devices Sale Price by Company
3.4 Key Manufacturers Chronic Heart Failure (CHF) Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Heart Failure (CHF) Devices Product Location Distribution
3.4.2 Players Chronic Heart Failure (CHF) Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Chronic Heart Failure (CHF) Devices by Geographic Region
4.1 World Historic Chronic Heart Failure (CHF) Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Chronic Heart Failure (CHF) Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Chronic Heart Failure (CHF) Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Chronic Heart Failure (CHF) Devices Sales Growth
4.4 APAC Chronic Heart Failure (CHF) Devices Sales Growth
4.5 Europe Chronic Heart Failure (CHF) Devices Sales Growth
4.6 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Growth
5 Americas
5.1 Americas Chronic Heart Failure (CHF) Devices Sales by Country
5.1.1 Americas Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023)
5.1.2 Americas Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023)
5.2 Americas Chronic Heart Failure (CHF) Devices Sales by Type
5.3 Americas Chronic Heart Failure (CHF) Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Heart Failure (CHF) Devices Sales by Region
6.1.1 APAC Chronic Heart Failure (CHF) Devices Sales by Region (2018-2023)
6.1.2 APAC Chronic Heart Failure (CHF) Devices Revenue by Region (2018-2023)
6.2 APAC Chronic Heart Failure (CHF) Devices Sales by Type
6.3 APAC Chronic Heart Failure (CHF) Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Chronic Heart Failure (CHF) Devices by Country
7.1.1 Europe Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023)
7.1.2 Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023)
7.2 Europe Chronic Heart Failure (CHF) Devices Sales by Type
7.3 Europe Chronic Heart Failure (CHF) Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Chronic Heart Failure (CHF) Devices by Country
8.1.1 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Type
8.3 Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Heart Failure (CHF) Devices
10.3 Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices
10.4 Industry Chain Structure of Chronic Heart Failure (CHF) Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Heart Failure (CHF) Devices Distributors
11.3 Chronic Heart Failure (CHF) Devices Customer
12 World Forecast Review for Chronic Heart Failure (CHF) Devices by Geographic Region
12.1 Global Chronic Heart Failure (CHF) Devices Market Size Forecast by Region
12.1.1 Global Chronic Heart Failure (CHF) Devices Forecast by Region (2024-2029)
12.1.2 Global Chronic Heart Failure (CHF) Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chronic Heart Failure (CHF) Devices Forecast by Type
12.7 Global Chronic Heart Failure (CHF) Devices Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Stanley Pharmaceuticals
13.4.1 Stanley Pharmaceuticals Company Information
13.4.2 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Stanley Pharmaceuticals Main Business Overview
13.4.5 Stanley Pharmaceuticals Latest Developments
13.5 New Haven Pharmaceuticals, Inc.
13.5.1 New Haven Pharmaceuticals, Inc. Company Information
13.5.2 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 New Haven Pharmaceuticals, Inc. Main Business Overview
13.5.5 New Haven Pharmaceuticals, Inc. Latest Developments
13.6 Boston Scientific Corporation
13.6.1 Boston Scientific Corporation Company Information
13.6.2 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Boston Scientific Corporation Main Business Overview
13.6.5 Boston Scientific Corporation Latest Developments
13.7 HeartWare
13.7.1 HeartWare Company Information
13.7.2 HeartWare Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.7.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 HeartWare Main Business Overview
13.7.5 HeartWare Latest Developments
13.8 Biovail Corporation
13.8.1 Biovail Corporation Company Information
13.8.2 Biovail Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biovail Corporation Main Business Overview
13.8.5 Biovail Corporation Latest Developments
13.9 Abiomed
13.9.1 Abiomed Company Information
13.9.2 Abiomed Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Abiomed Main Business Overview
13.9.5 Abiomed Latest Developments
13.10 Symplmed Pharmaceuticals
13.10.1 Symplmed Pharmaceuticals Company Information
13.10.2 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Symplmed Pharmaceuticals Main Business Overview
13.10.5 Symplmed Pharmaceuticals Latest Developments
13.11 Berlin Heart GmbH
13.11.1 Berlin Heart GmbH Company Information
13.11.2 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Berlin Heart GmbH Main Business Overview
13.11.5 Berlin Heart GmbH Latest Developments
13.12 ReliantHeart, Inc.
13.12.1 ReliantHeart, Inc. Company Information
13.12.2 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 ReliantHeart, Inc. Main Business Overview
13.12.5 ReliantHeart, Inc. Latest Developments
13.13 Cardiokinetix
13.13.1 Cardiokinetix Company Information
13.13.2 Cardiokinetix Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Cardiokinetix Main Business Overview
13.13.5 Cardiokinetix Latest Developments
13.14 Biotronik
13.14.1 Biotronik Company Information
13.14.2 Biotronik Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Biotronik Main Business Overview
13.14.5 Biotronik Latest Developments
13.15 Jarvik Heart
13.15.1 Jarvik Heart Company Information
13.15.2 Jarvik Heart Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
13.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Jarvik Heart Main Business Overview
13.15.5 Jarvik Heart Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Chronic Heart Failure (CHF) Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Chronic Heart Failure (CHF) Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Implantable Left Ventricular Assist Device (LVAD)
Table 4. Major Players of Biventricular Pacemaker
Table 5. Major Players of Implantable Cardioverter-defibrillators (ICDs)
Table 6. Major Players of Continuous Positive Air Pressure Device (CPAP)
Table 7. Major Players of Bi-level Positive Air Pressure Device (BiPAP)
Table 8. Major Players of Heart Pumps
Table 9. Global Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units)
Table 10. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023)
Table 11. Global Chronic Heart Failure (CHF) Devices Revenue by Type (2018-2023) & ($ million)
Table 12. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2018-2023)
Table 13. Global Chronic Heart Failure (CHF) Devices Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units)
Table 15. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023)
Table 16. Global Chronic Heart Failure (CHF) Devices Revenue by Application (2018-2023)
Table 17. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2018-2023)
Table 18. Global Chronic Heart Failure (CHF) Devices Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Chronic Heart Failure (CHF) Devices Sales by Company (2018-2023) & (K Units)
Table 20. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company (2018-2023)
Table 21. Global Chronic Heart Failure (CHF) Devices Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company (2018-2023)
Table 23. Global Chronic Heart Failure (CHF) Devices Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Chronic Heart Failure (CHF) Devices Producing Area Distribution and Sales Area
Table 25. Players Chronic Heart Failure (CHF) Devices Products Offered
Table 26. Chronic Heart Failure (CHF) Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Chronic Heart Failure (CHF) Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Chronic Heart Failure (CHF) Devices Sales Market Share Geographic Region (2018-2023)
Table 31. Global Chronic Heart Failure (CHF) Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Chronic Heart Failure (CHF) Devices Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Country/Region (2018-2023)
Table 35. Global Chronic Heart Failure (CHF) Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) & (K Units)
Table 38. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2018-2023)
Table 39. Americas Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2018-2023)
Table 41. Americas Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units)
Table 42. Americas Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units)
Table 43. APAC Chronic Heart Failure (CHF) Devices Sales by Region (2018-2023) & (K Units)
Table 44. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2018-2023)
Table 45. APAC Chronic Heart Failure (CHF) Devices Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2018-2023)
Table 47. APAC Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units)
Table 48. APAC Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units)
Table 49. Europe Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) & (K Units)
Table 50. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2018-2023)
Table 51. Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2018-2023)
Table 53. Europe Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units)
Table 54. Europe Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Chronic Heart Failure (CHF) Devices
Table 62. Key Market Challenges & Risks of Chronic Heart Failure (CHF) Devices
Table 63. Key Industry Trends of Chronic Heart Failure (CHF) Devices
Table 64. Chronic Heart Failure (CHF) Devices Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Chronic Heart Failure (CHF) Devices Distributors List
Table 67. Chronic Heart Failure (CHF) Devices Customer List
Table 68. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Chronic Heart Failure (CHF) Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Chronic Heart Failure (CHF) Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Chronic Heart Failure (CHF) Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Chronic Heart Failure (CHF) Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Chronic Heart Failure (CHF) Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Chronic Heart Failure (CHF) Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Chronic Heart Failure (CHF) Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Chronic Heart Failure (CHF) Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. Medtronic Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 83. Medtronic Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 84. Medtronic Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Medtronic Main Business
Table 86. Medtronic Latest Developments
Table 87. Abbott Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 88. Abbott Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 89. Abbott Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Abbott Main Business
Table 91. Abbott Latest Developments
Table 92. Johnson & Johnson Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 93. Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 94. Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Johnson & Johnson Main Business
Table 96. Johnson & Johnson Latest Developments
Table 97. Stanley Pharmaceuticals Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 98. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 99. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Stanley Pharmaceuticals Main Business
Table 101. Stanley Pharmaceuticals Latest Developments
Table 102. New Haven Pharmaceuticals, Inc. Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 103. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 104. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. New Haven Pharmaceuticals, Inc. Main Business
Table 106. New Haven Pharmaceuticals, Inc. Latest Developments
Table 107. Boston Scientific Corporation Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 108. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 109. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Boston Scientific Corporation Main Business
Table 111. Boston Scientific Corporation Latest Developments
Table 112. HeartWare Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 113. HeartWare Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 114. HeartWare Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. HeartWare Main Business
Table 116. HeartWare Latest Developments
Table 117. Biovail Corporation Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 118. Biovail Corporation Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 119. Biovail Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Biovail Corporation Main Business
Table 121. Biovail Corporation Latest Developments
Table 122. Abiomed Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 123. Abiomed Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 124. Abiomed Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Abiomed Main Business
Table 126. Abiomed Latest Developments
Table 127. Symplmed Pharmaceuticals Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 128. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 129. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Symplmed Pharmaceuticals Main Business
Table 131. Symplmed Pharmaceuticals Latest Developments
Table 132. Berlin Heart GmbH Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 133. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 134. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Berlin Heart GmbH Main Business
Table 136. Berlin Heart GmbH Latest Developments
Table 137. ReliantHeart, Inc. Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 138. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 139. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. ReliantHeart, Inc. Main Business
Table 141. ReliantHeart, Inc. Latest Developments
Table 142. Cardiokinetix Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 143. Cardiokinetix Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 144. Cardiokinetix Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Cardiokinetix Main Business
Table 146. Cardiokinetix Latest Developments
Table 147. Biotronik Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 148. Biotronik Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 149. Biotronik Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Biotronik Main Business
Table 151. Biotronik Latest Developments
Table 152. Jarvik Heart Basic Information, Chronic Heart Failure (CHF) Devices Manufacturing Base, Sales Area and Its Competitors
Table 153. Jarvik Heart Chronic Heart Failure (CHF) Devices Product Portfolios and Specifications
Table 154. Jarvik Heart Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Jarvik Heart Main Business
Table 156. Jarvik Heart Latest Developments
List of Figures
Figure 1. Picture of Chronic Heart Failure (CHF) Devices
Figure 2. Chronic Heart Failure (CHF) Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Heart Failure (CHF) Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Chronic Heart Failure (CHF) Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Chronic Heart Failure (CHF) Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Implantable Left Ventricular Assist Device (LVAD)
Figure 10. Product Picture of Biventricular Pacemaker
Figure 11. Product Picture of Implantable Cardioverter-defibrillators (ICDs)
Figure 12. Product Picture of Continuous Positive Air Pressure Device (CPAP)
Figure 13. Product Picture of Bi-level Positive Air Pressure Device (BiPAP)
Figure 14. Product Picture of Heart Pumps
Figure 15. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type in 2022
Figure 16. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2018-2023)
Figure 17. Chronic Heart Failure (CHF) Devices Consumed in Hospital
Figure 18. Global Chronic Heart Failure (CHF) Devices Market: Hospital (2018-2023) & (K Units)
Figure 19. Chronic Heart Failure (CHF) Devices Consumed in Clinic
Figure 20. Global Chronic Heart Failure (CHF) Devices Market: Clinic (2018-2023) & (K Units)
Figure 21. Chronic Heart Failure (CHF) Devices Consumed in Household
Figure 22. Global Chronic Heart Failure (CHF) Devices Market: Household (2018-2023) & (K Units)
Figure 23. Chronic Heart Failure (CHF) Devices Consumed in Others
Figure 24. Global Chronic Heart Failure (CHF) Devices Market: Others (2018-2023) & (K Units)
Figure 25. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2022)
Figure 26. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application in 2022
Figure 27. Chronic Heart Failure (CHF) Devices Sales Market by Company in 2022 (K Units)
Figure 28. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Company in 2022
Figure 29. Chronic Heart Failure (CHF) Devices Revenue Market by Company in 2022 ($ Million)
Figure 30. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Company in 2022
Figure 31. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Geographic Region (2018-2023)
Figure 32. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Geographic Region in 2022
Figure 33. Americas Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units)
Figure 34. Americas Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions)
Figure 35. APAC Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units)
Figure 36. APAC Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions)
Figure 37. Europe Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units)
Figure 38. Europe Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions)
Figure 39. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales 2018-2023 (K Units)
Figure 40. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue 2018-2023 ($ Millions)
Figure 41. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Country in 2022
Figure 42. Americas Chronic Heart Failure (CHF) Devices Revenue Market Share by Country in 2022
Figure 43. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023)
Figure 44. Americas Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023)
Figure 45. United States Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. Canada Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 47. Mexico Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. Brazil Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 49. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Region in 2022
Figure 50. APAC Chronic Heart Failure (CHF) Devices Revenue Market Share by Regions in 2022
Figure 51. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023)
Figure 52. APAC Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023)
Figure 53. China Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. Japan Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. South Korea Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. Southeast Asia Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. India Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 58. Australia Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. China Taiwan Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 60. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Country in 2022
Figure 61. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Country in 2022
Figure 62. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023)
Figure 63. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023)
Figure 64. Germany Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. France Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. UK Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 67. Italy Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. Russia Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 69. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Country in 2022
Figure 70. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Country in 2022
Figure 71. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2018-2023)
Figure 72. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2018-2023)
Figure 73. Egypt Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. South Africa Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 75. Israel Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 76. Turkey Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 77. GCC Country Chronic Heart Failure (CHF) Devices Revenue Growth 2018-2023 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of Chronic Heart Failure (CHF) Devices in 2022
Figure 79. Manufacturing Process Analysis of Chronic Heart Failure (CHF) Devices
Figure 80. Industry Chain Structure of Chronic Heart Failure (CHF) Devices
Figure 81. Channels of Distribution
Figure 82. Global Chronic Heart Failure (CHF) Devices Sales Market Forecast by Region (2024-2029)
Figure 83. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 84. Global Chronic Heart Failure (CHF) Devices Sales Market Share Forecast by Type (2024-2029)
Figure 85. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 86. Global Chronic Heart Failure (CHF) Devices Sales Market Share Forecast by Application (2024-2029)
Figure 87. Global Chronic Heart Failure (CHF) Devices Revenue Market Share Forecast by Application (2024-2029)

※参考情報

慢性心不全（CHF）用装置は、心臓からの血液供給が不十分であるため、身体のさまざまな機能が影響を受ける慢性心不全の管理や治療を目的とした医療機器です。心不全は多くの場合、心筋梗塞や高血圧、心臓弁膜症などの心疾患によって引き起こされます。CHFは患者の生活の質を大きく左右する疾患であり、そのマネジメントは非常に重要です。これに対応するための装置にはさまざまな種類があり、それぞれ特定の役割を果たします。

慢性心不全用装置の一つの主要な特徴は、心臓のポンプ機能を補助または強化することです。心不全のタイプによって症状や重症度は異なりますが、これらの装置は一般的に心臓の働きを助け、血液の循環を改善することを目指しています。また、体内の液体バランスの調節や心拍数の管理、さらには症状のモニタリングを行うことができるものもあります。

慢性心不全用装置の種類は多岐にわたりますが、代表的なものには以下のようなものがあります。まず、心臓再同期療法（CRT）デバイスは、心臓の両側を同時に刺激することにより、心臓のポンプ機能を改善するために使用されます。心臓ペースメーカーや植込み型除細動器（ICD）もこれに含まれ、特に不整脈が合併するCHFの患者に有効です。

次に、機械的補助装置としては、心室補助装置（VAD）が挙げられます。VADは、心臓のポンプ機能が severely impaired された場合に、血液を身体に送り出す役割を果たします。これにより、心不全患者の生存率を高め、また心臓移植までの橋渡しとしても利用されることがあります。

さらに、最近ではウェアラブルデバイスやリモートモニタリングシステムも登場しています。これらの装置では患者の心機能やバイタルサインをリアルタイムで監視し、異常を早期に発見することが可能となります。特に高齢者や慢性の持病を持つ患者にとって、自宅での健康管理を容易にする役割を果たしています。

慢性心不全用装置の用途は大変広範であり、患者の状態に応じて選択されます。例えば、心不全による入院を繰り返す患者に対しては、CRTやVADが適している場合があります。また、初期段階の管理には、ウェアラブルデバイスを用いて日常的に状態をモニタリングし、疾患の進行を防ぐことが期待されます。

関連する技術としては、バイオセンサーやデータ分析技術が挙げられます。これらの技術は、患者の健康データを収集し、分析することによってより効果的な治療を実現するために不可欠です。例えば、近年はAIを用いたシステムが開発され、患者のデータから今後の心不全のリスクを予測する試みも行われています。

慢性心不全用装置の発展は、臨床現場での患者ケアに革新をもたらしています。これにより、患者の生活の質が向上し、治療の選択肢が広がると同時に、医療コストの削減にも寄与しています。しかし、このような装置を効果的に活用するためには、医療従事者の適切な教育と、患者への十分な情報提供が不可欠です。また、技術の進歩に伴い、装置の安全性や操作性の向上も求められています。

総じて、慢性心不全用装置は心不全の治療において重要な役割を果たしています。これらの装置は、患者の生活の質を高めるために設計されており、今後もさらなる技術革新が期待されます。心臓病専門医や看護師と連携しながら、患者それぞれの状態に合った最適な治療を提供することが重要です。


★調査レポート[世界の慢性心不全（CHF）用装置市場予測 2023年-2029年] (コード：LP23MY4350)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の慢性心不全（CHF）用装置市場予測 2023年-2029年]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆